These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6797226)

  • 21. Acute intoxication with sodium valproate.
    Chadwick DW; Cumming WJ; Livingstone I; Cartlidge NE
    Ann Neurol; 1979 Dec; 6(6):552-3. PubMed ID: 119482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium valproate.
    N Z Med J; 1979 Oct; 90(645):298-9. PubMed ID: 117405
    [No Abstract]   [Full Text] [Related]  

  • 23. Sodium valproate in the treatment of childhood epilepsies.
    Maheshwari MC
    Indian Pediatr; 1984 Jun; 21(6):439-46. PubMed ID: 6439636
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: The effect of sodium valproate (Epilim) on the EEG.
    Maheshwari MC; Jeavons PM
    Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):429. PubMed ID: 51737
    [No Abstract]   [Full Text] [Related]  

  • 25. Lack of valproic acid-associated weight gain in prepubertal children.
    Espinosa PS; Salazar JC; Yu L; Mendiondo MS; Robertson WC; Baumann RJ
    Pediatr Neurol; 2008 Sep; 39(3):177-80. PubMed ID: 18725062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sodium valproate, platelet dysfunction and bleeding (author's transl)].
    Loiseau P
    Nouv Presse Med; 1981 Dec; 10(46):3789-90. PubMed ID: 6798554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum total amylase, pancreatic amylase and lipase activities in epileptic children treated with sodium valproate monotherapy.
    Voudris K; Attilakos A; Katsarou E; Mastroyianni S; Dimou S; Skardoutsou A; Prassouli A; Garoufi A
    Brain Dev; 2006 Oct; 28(9):572-5. PubMed ID: 16730152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Our experiences in the treatment of epilepsy with sodium valproate (convulex)].
    Bilikiewicz A; Rudy B
    Psychiatr Pol; 1978; 12(5-6):623-5. PubMed ID: 364516
    [No Abstract]   [Full Text] [Related]  

  • 29. [Valproate sustained release in the treatment of epilepsy].
    Stefan H; Fraunberger B
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):681-6. PubMed ID: 16283612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipid peroxidation in adult epileptic patients treated with valproic acid].
    Martínez-Ballesteros C; Pita-Calandre E; Sánchez-González Y; Rodríguez-López CM; Agil A
    Rev Neurol; 2004 Jan 16-31; 38(2):101-6. PubMed ID: 14752705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem.
    Fudio S; Carcas A; Piñana E; Ortega R
    J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy.
    Attilakos A; Papakonstantinou E; Schulpis K; Voudris K; Katsarou E; Mastroyianni S; Garoufi A
    Epilepsy Res; 2006 Oct; 71(2-3):229-32. PubMed ID: 16889940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium valproate in the treatment of intractable childhood epilepsy.
    Barnes SE; Bower BD
    Dev Med Child Neurol; 1975 Apr; 17(2):175-81. PubMed ID: 1093915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of long-term therapy with sodium valproate on nail and serum trace element status in epileptic children.
    Armutcu F; Ozerol E; Gurel A; Kanter M; Vural H; Yakinci C; Akyol O
    Biol Trace Elem Res; 2004; 102(1-3):1-10. PubMed ID: 15621922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
    Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A
    Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Monitoring sodium valproate treatment of epilepsy in the development years].
    Sobaniec W; Wroński B; Czerwińska-Ciechan K; Szczepaniak L
    Neurol Neurochir Pol; 1987; 21(1):1-5. PubMed ID: 3112594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Side effects of valproate in epileptic children].
    John K; Ludwig U; Daute KH
    Kinderarztl Prax; 1987 Apr; 55(4):185-9. PubMed ID: 3110484
    [No Abstract]   [Full Text] [Related]  

  • 40. Proceedings: Sodium valproate (Epilim) and photosensitivity. A preliminary report.
    Herrick CE; Maheshwari MC
    Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):429. PubMed ID: 51735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.